Nature of Disclosure: Regulatory filing pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015, announcing the company's diversification into medical devices and consumables business through its subsidiary.

Key Development: Royal Sandur MedTech Private Limited, a wholly owned subsidiary of The Sandur Manganese & Iron Ores Limited (SMIORE), has executed a lease deed on 19 October 2026 with Andhra Pradesh MedTech Zone Limited (a Government of Andhra Pradesh undertaking) for setting up a manufacturing unit at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam.

Lease Details:

  • Developed land measuring 6.2 acres (approximately 25,090 square meters)
  • Infrastructure provided by AMTZ: road, power, water, and effluent infrastructure
  • Lease tenure: 33 years from date of execution
  • Exclusive right to convert leasehold rights into freehold ownership after 10 years from date of business commissioning

Additional Space: The subsidiary has also taken office space at World Trade Center AMTZ to support project development.

Strategic Context: This move represents SMIORE's comprehensive diversification strategy beyond its core mining and metals businesses, which currently span three segments: Mining (Manganese & Iron Ores), Ferroalloys, and Coke and Energy. The company also has presence in specialty steel through subsidiary Royal Sandur Metals Private Limited.

Management Commentary:

  • Bahirji A. Ghorpade, Managing Director, stated this diversification is about "building new engines of growth" and noted the medical devices sector offers considerable opportunities for domestic manufacturing
  • Dr. Jitendra Sharma, Managing Director & Founder CEO of AMTZ, welcomed the investment as reflecting growing confidence in India's medical technology manufacturing capabilities

Future Plans: Further details on capital expenditure plans and project timelines will be announced in due course. Financial impact not quantified in the disclosure.

Regulatory Reference: Filed pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015.